Insider: Neervannan Seshadri Chief Operating Officer - Tarsus Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 82,791 | 0 | 82,791 |
| Value | $5,805,304.92 | $0.00 | $5,805,304.92 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/20/2026 | DDS | 2,989 | Direct | COM | $66.75 | $199,515.75 | 82,791 |
| 03/19/2026 | DDS | 4,589 | Direct | COM | $67.00 | $307,463.00 | 85,780 |
| 03/18/2026 | DDS | 3,610 | Direct | COM | $68.71 | $248,043.10 | 90,369 |
| 03/17/2026 | DDS | 3,125 | Direct | COM | $69.42 | $216,937.50 | 93,979 |
| 03/04/2026 | DDS | 8,366 | Direct | COM | $76.67 | $641,421.22 | 70,817 |
| 03/20/2025 | DDS | 2,435 | Direct | COM | $50.11 | $122,017.85 | 79,682 |
| 03/19/2025 | DDS | 2,543 | Direct | COM | $47.40 | $120,538.20 | 82,117 |
| 03/18/2025 | DDS | 2,605 | Direct | COM | $46.29 | $120,585.45 | 84,660 |
| 03/18/2024 | DDS | 4,879 | Direct | COM | $30.60 | $149,297.40 | 64,767 |
| 03/20/2023 | DDS | 380 | Direct | COM | $12.61 | $4,791.80 | 55,837 |
| 03/17/2023 | DDS | 360 | Direct | COM | $13.28 | $4,780.80 | 56,217 |
| 03/16/2023 | DDS | 357 | Direct | COM | $13.43 | $4,794.51 | 56,577 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research